Elena Casanova
Turin, 10060, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas.
Journal: Cell reports
Published: September 16, 2022
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor.
Journal: International journal of molecular sciences
Published: September 05, 2022
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor.
Journal: Frontiers in immunology
Published: September 15, 2021
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma.
Journal: Cell reports
Published: September 21, 2020
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3.
Journal: International journal of molecular sciences
Published: June 30, 2020
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro.
Journal: British journal of pharmacology
Published: September 07, 2018
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.
Journal: EMBO molecular medicine
Published: May 04, 2016
TNF-α promotes invasive growth through the MET signaling pathway.
Journal: Molecular oncology
Published: August 01, 2014
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
Journal: Cancer research
Published: June 29, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026